These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 26767868)

  • 1. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
    Chang UI; Kim HW; Wie SH
    Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis.
    Chang UI; Kim HW; Wie SH
    Yonsei Med J; 2015 Sep; 56(5):1266-73. PubMed ID: 26256969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis.
    Chang UI; Kim HW; Noh YS; Wie SH
    Korean J Intern Med; 2015 May; 30(3):372-83. PubMed ID: 25995668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
    Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience.
    Wie SH; Kim HW; Chang UI
    Microb Drug Resist; 2013 Aug; 19(4):316-22. PubMed ID: 23473263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
    Park SH; Choi SM; Chang YK; Lee DG; Cho SY; Lee HJ; Choi JH; Yoo JH
    J Antimicrob Chemother; 2014 Oct; 69(10):2848-56. PubMed ID: 24928854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
    Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
    Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women.
    Chang UI; Kim HW; Wie SH
    Antimicrob Agents Chemother; 2015 May; 59(5):2488-95. PubMed ID: 25645837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of extended-spectrum beta-lactamase on acute pyelonephritis treated with empirical ceftriaxone.
    Lee S; Song DY; Cho SH; Kwon KT
    Microb Drug Resist; 2014 Feb; 20(1):39-44. PubMed ID: 23941639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
    Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
    Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Cho SY; Choi SM; Park SH; Lee DG; Choi JH; Yoo JH
    Korean J Intern Med; 2016 Jan; 31(1):156-61. PubMed ID: 26767869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of extended-spectrum β-lactamase production on treatment outcomes of acute pyelonephritis caused by escherichia coli in patients without health care-associated risk factors.
    Park SH; Choi SM; Lee DG; Cho SY; Lee HJ; Choi JK; Choi JH; Yoo JH
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1962-8. PubMed ID: 25583722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis.
    Lee SS; Kim Y; Chung DR
    J Infect; 2011 Feb; 62(2):159-64. PubMed ID: 21055417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of amoxicillin-susceptible Escherichia coli in fresh uncultured urine: a new tool to limit the use of broad-spectrum empirical therapy of community-acquired pyelonephritis.
    Chapelet G; Corvec S; Montassier E; Herbreteau G; Berrut G; Batard E; de Decker L
    Int J Antimicrob Agents; 2016 Jun; 47(6):486-9. PubMed ID: 27211827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
    Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
    Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between phylogenetic groups, antibiotic resistance and patient characteristics in terms of adhesin genes in cystitis and pyelonephritis isolates of Escherichia coli.
    Er DK; Dundar D; Uzuner H; Osmani A
    Microb Pathog; 2015 Dec; 89():188-94. PubMed ID: 26518125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
    Yoon YK; Kim JH; Sohn JW; Yang KS; Kim MJ
    Int J Antimicrob Agents; 2017 Apr; 49(4):410-415. PubMed ID: 28263710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.